Summary
- The Supreme Court has directed the Centre to consider forming a committee to investigate pharmaceutical companies offering incentives to doctors for prescribing their drugs.
- Justices Vikram Nath and Sandeep Mehta raised concerns about the adequacy of the current regulatory framework governing these practices.
- The proposed three-member panel will assess whether stronger statutory safeguards are needed to prevent unethical inducements in the medical sector.
- This intervention highlights the potential financial burden on patients and questions if commercial interests should influence medical prescriptions.
Join the discussion ā sign up to comment, upvote, and save articles.